Welchol and Dilantin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Welchol (colesevelam hydrochloride) and Dilantin (phenytoin sodium). Common drug interactions include oesophageal candidiasis among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Welchol and Dilantin. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Welchol?

Welchol has active ingredients of colesevelam hydrochloride. It is often used in high blood cholesterol. eHealthMe is studying from 11,309 Welchol users. Check the latest studies of Welchol.

What is Dilantin?

Dilantin has active ingredients of phenytoin sodium. It is often used in epilepsy. eHealthMe is studying from 20,858 Dilantin users. Check the latest studies of Dilantin.



On Jul, 05, 2026

16 people who take Welchol and Dilantin together, and have interactions are studied.

Welchol and Dilantin drug interactions.

What are the common drug interactions of Welchol and Dilantin, by gender? *:

female:

  1. Oesophageal candidiasis (fungal infection of oesophagus)
  2. Oesophageal stenosis (narrowing of oesophagus)
  3. Oral candidiasis (fungal infection of mouth)
  4. Osteoporosis (bones weak and more likely to break)
  5. Pain
  6. Pericardial effusion (fluid around the heart)
  7. Pleural effusion (water on the lungs)
  8. Productive cough
  9. Pulmonary hypertension (increase in blood pressure in the lung artery)
  10. Pyrexia (fever)

male:

  1. Asthenia (weakness)
  2. Constipation
  3. Anxiety
  4. Atelectasis (partial or complete collapse of the lung)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Blood creatinine increased
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  9. Craniopharyngioma (a type of brain tumour derived from pituitary gland embryonic tissue)
  10. Diffuse large b-cell lymphoma (cancer of b cells, a type of white blood cell)

What are the common drug interactions of Welchol and Dilantin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Petit mal epilepsy (absence seizure)

40-49:

  1. Gamma-glutamyltransferase increased
  2. Alanine aminotransferase increased
  3. Aspartate aminotransferase increased
  4. Muscle twitching
  5. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  6. Simple partial seizures (seizures which affect only a small region of the brain)

50-59:

  1. Wheezing (a high-pitched whistling sound made while you breath)
  2. Abdominal pain
  3. Acute sinusitis
  4. Alopecia (absence of hair from areas of the body)
  5. Anaemia (lack of blood)
  6. Arthropathy
  7. Asthma
  8. Blood alkaline phosphatase increased
  9. Breast mass
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

60+:

  1. Abdominal discomfort
  2. Dizziness
  3. Dizziness (excl vertigo)
  4. Drug level decreased
  5. Emotional distress
  6. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  7. General physical health deterioration (weak health status)
  8. Injury
  9. Joint contracture (a permanent shortening of a muscle or joint)
  10. Mobility decreased (ability to move is reduced)

What are the existing conditions these people have? *

  1. Wheezing (a high-pitched whistling sound made while you breath): 1 person, 6.25%
  2. Inflammation: 1 person, 6.25%
  3. Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 1 person, 6.25%
  4. Hypersensitivity: 1 person, 6.25%
  5. Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 1 person, 6.25%
  6. Headache (pain in head): 1 person, 6.25%
  7. Fungal Infection: 1 person, 6.25%
  8. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 6.25%
  9. Dyspnea (difficult or laboured breathing): 1 person, 6.25%
  10. Dizziness: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Welchol and Dilantin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Welchol and Dilantin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Welchol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dilantin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Welchol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dilantin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on colesevelam hydrochloride and phenytoin sodium (the active ingredients of Welchol and Dilantin, respectively), and Welchol and Dilantin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: